Navigation Links
New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease
Date:8/11/2008

Mutation Causing Mitochondrial Disease More Common Than Previously Believed

PITTSBURGH, Aug. 11 /PRNewswire-USNewswire/ -- The United Mitochondrial Disease Foundation (UMDF) today announced landmark research finding that one in every 200 people has a DNA mutation that could potentially cause a mitochondrial disease in them or their offspring. Mitochondrial disease is a devastating and often fatal disease, and mitochondrial disorders are at the core of many well known diseases and chronic illnesses, such as Alzheimer's disease, Parkinson's disease and autism spectrum disorders. This research, which was partially funded by UMDF, was conducted by Patrick Chinnery, MBBS, PhD, MRCPath, FRCP, Wellcome Senior Fellow in Clinical Genetics and professor of neurogenetics at Newcastle University in the UK. Dr. Chinnery's findings are published in the current issue of the American Journal of Human Genetics.

"This ground breaking discovery confirms what researchers and experts have believed for some time - mitochondrial disease is not rare," said Charles A. Mohan, Jr., Executive Director and CEO of UMDF. "We now know that 1 in 200 people carry the mutation for this horrible, debilitating disease. This discovery underscores the need for additional research funding to help better diagnose and treat affected individuals and to learn more about how mitochondrial dysfunction is connected to other diseases."

Mitochondrial diseases are extremely complicated and often go undiagnosed or misdiagnosed for years. They develop when the mitochondria - the body's main energy source - do not function properly. Mitochondria are responsible for creating more than 90 percent of the energy needed by the body to sustain life and support growth. Because they are in almost all human cells, this "power failure" results in disease that can affect almost any body tissue. Therefore, the severity of symptoms and how the disease manifests itself can vary from person to person. One
'/>"/>

SOURCE United Mitochondrial Disease Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
2. New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans
3. New AAHC Toolkit Available to Optimize Clinical Research Administration
4. New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer
5. Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
6. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
7. Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic
8. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
9. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
10. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
11. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Reportlinker.com announces that a new market research report ... and Taiwanese Markets for Minimally Invasive Spinal Devices ... The market for MIS spinal devices in the ... at a fast pace, albeit at different rates in ... China , where MIS spinal fusion ...
(Date:9/2/2014)... , Sept. 2, 2014 The Pharmaceutical Care ... benefit managers (PBMs), today filed a lawsuit in ... new Iowa law that restricts ... for the state,s employers and consumers.  ... by severely restricting the use of Maximum Allowable Cost ...
(Date:9/2/2014)... 2, 2014  XBiotech announced today interim results ... in the US for its anti-cancer agent Xilonix™. ... therapy, is being evaluated in advanced colorectal cancer ... The primary endpoint of the study is overall ... a control population provided only palliative therapy for ...
Breaking Medicine Technology:Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9Lawsuit Challenges Iowa Health Mandate that Forces Employers to Pay More for Prescription Drugs 2XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2
... SEOUL, South Korea, Feb. 16, 2012   ,The ... the largest health care provider festival, is ... This Exhibition, for enhancing a national ... of hospital-related industry, is hosted by Korea ...
... Therapeutics, Inc. (NASDAQ: HALO ) today announced the ... its common stock, including 1,020,000 shares sold pursuant to the ... underwriter. All of the shares were offered by Halozyme at ... proceeds to Halozyme from this offering were approximately $81.8 million, ...
Cached Medicine Technology:To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 2To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 3Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock 2Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock 3
(Date:9/2/2014)... (PRWEB) September 03, 2014 Autumn ... Top10BestSEOHosting.com wants to celebrate the new season with ... of research and announced that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ... hosting suppliers of 2014. , Since 2002 ... hosting provider, and the company’s reputation for reliability ...
(Date:9/2/2014)... pot might be risky business for women, according ... study is the first to demonstrate sex differences ... , Psychology professor Rebecca Craft showed that, thanks ... least 30 percent more sensitive than males to ... in cannabis. Females also develop tolerance to THC ...
(Date:9/2/2014)... Angeles, CA (PRWEB) September 03, 2014 ... health enthusiasts, bodybuilders, and athletes obtain the latest ... its launch. The site, which focuses mainly on ... dedicated to helping individuals increase their workout capacity ... an article available on Top Creatine Monohydrate, Muscle ...
(Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Officer and Chief Information Officer Strategy Roundtables on ... , Becker's Hospital Review Chief Executive Officer and ... and health system Chief Executive Officers, Chief Financial ... health system executives through high-quality continuing education, ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the bamboo industry, ... bamboo floors to celebrate the coming of autumn. ... the frequent callers, BambooIndustry.com launched a promotion for its ... woven floors, BambooIndustry.com provides many kinds of wonderful items ... woven floors, click lock floors, wide plank floors and ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Celebrates The Coming Of Autumn And Release Reseller Hosting Suppliers Of 2014 2Health News:Estrogen increases cannabis sensitivity 2Health News:Estrogen increases cannabis sensitivity 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
... Inc. (Nasdaq: MEDQ ), the largest Medical Transcription ... the positive resolution of several material legal matters , ... Investigation , , As ... documents from the United States Department of Justice ("DOJ") on ...
... College of Surgeons (ACS) today recognized the Institute of Medicine ... was released on December 2, 2008, by the IOM Committee ... to Improve Patient Safety. , ... conclusion that further reductions in the mandated 80-hour work week ...
... YORK, Dec. 3, 2008 Forest Laboratories, Inc. (NYSE: ... of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) ... has received a copy of the tender offer to purchase ... stock, which represents less than 1 per cent of its ...
... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced ... "Adapting Specialty Pharma Strategy,To Market Conditions" at the 2008 ... at 10:00 am (ET) in New York City. , ... of the panel discussion will be available on the ...
... outperform animal and human derived serum in CHO cell culture. ... ... Cellastim has proven to be a robust replacement for serum derived ... and productivity of CHO cell lines across a variety of chemically ...
... N.J., Dec. 3 As previously announced, HLTH Corporation (Nasdaq: ... (Nasdaq: WBMD ), will be holding their Annual Meetings ... 10, 2008. , , ... the Internet. To listen to the audio webcast of the meetings, ...
Cached Medicine News:Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2Health News:HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders 2
...
... The mecA ASR contains primers and a FAM-labeled ... bp region of the mecA gene. In addition, ... and DNA for an internal control sequence. This ... and Texas Red reporter dyes such as the ...
... features the ability to use a separate, ... a pre-loaded nitinol filter with a dual-ended ... fully rapid exchange system, the SpideRX Device ... applications:, Carotid Indication - ,The SpideRX Embolic ...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Medicine Products: